We put better health within reach, every day.

By creating high-quality medicines and making them accessible to the people who need them, we help to shape a healthier world that enriches all our communities.

Who is Hikma?

At Hikma we help put better health within reach, every day. By creating high-quality medicines and making them accessible to the people who need them, we help to shape a healthier world that enriches all our communities. We help deliver this by living our culture, delivering our strategy, and acting responsibly. We are a trusted, reliable partner and dependable source of over 670 (as of 31 December 2021) high-quality generic, specialty and branded pharmaceutical products that hospitals, physicians and pharmacists need to treat their patients across North America, MENA and Europe. We have 32 manufacturing facilities, 7 R&D centres and 8,700+ employees worldwide.

Our leadership

Our leadership

Our Board is responsible for corporate governance and company performance while our Executive Committee manages the day-to-day business. The Committee meets regularly to provide organisational direction and take strategic business decisions.
Our partners

Our partners

Our partners collaborate with us because of our reputation for quality, our strong brand recognition, and our US FDA-inspected manufacturing plants. Organisations we work with know they can rely on us to deliver consistently, in all our markets.
Ethics & compliance

Ethics & compliance

We have always been committed to high standards of ethical conduct. In our business and in our dealings with other people. At the heart of this are our three values: Innovation. Caring. Collaboration. These shape the way our people think, work and behave. And ensure the sustainability of our company. In 2017, we achieved the highest ranking of any pharmaceutical company in the UK’s Institute of Directors' Good Governance Report.
Our history

Our history

Our company was founded on our dedication to transforming people’s lives by providing the quality medicine and support they need every day. More than forty years ago, we established our branded generic medicines business in the Middle East and North Africa. From these humble beginnings, we have grown into a $2bn+ global pharmaceuticals business.

Last reviewed 30 April 2022